March 16, 2016
A lawyer for indicted pharmaceutical executive Martin Shkreli told a New York federal judge on Wednesday that one of his former companies, Retrophin, is legally obligated to pay more than $5 million in his legal fees, including a $2.6 million settlement in an investor suit.